Decision Memo

Flare-timeline photo journal for eczema and psoriasis patients

Record the team verdict, rationale, and reviewer leans locally, then print or share a source-anchored memo.

Markdown export

Agent and email version.

# Decision Memo: Flare-timeline photo journal for eczema and psoriasis patients

Full report: https://ideanavigatorai.com/ideas/photo-journal-app-for-chronic-skin-condition-patients/
Recorded: Not recorded

## Decision
- Team verdict: Park
- Validation verdict: Research (64/100)
- Confidence: 62%
- Recommendation: Keep this parked until the team has evidence for the next validation step: Recruit fifteen eczema patients to log photos weekly for one month, then ask their dermatologist whether the timeline changed the visit and measure willingness to pay.

## Team rationale
No team rationale recorded yet.

## Reviewers
- No named reviewers recorded.

## Source anchors
- Buyer: Adult eczema or psoriasis patient tracking flares between dermatology visits
- Market: Chronic skin condition self-management
- Problem: Patients struggle to recall when flares started, what triggered them, and whether treatment is working, so dermatology visits rely on vague memory instead of dated photo evidence.
- Thesis: Flare-timeline photo journal for eczema and psoriasis patients should be tested as a narrow first-win workflow for Adult eczema or psoriasis patient tracking flares between dermatology visits.
- Source: https://www.aad.org/
- Source: https://nationaleczema.org/

## Validation rubric
Rubric version: INAV-VALIDATION-2026-06-04

### Demand signal - 5.6/10 (24% weight)
Demand looks thin because the report has 2 source-backed signal(s), an editorial confidence of 62/100, and a defined buyer in Chronic skin condition self-management.

- Eczema and psoriasis are relapsing-remitting conditions where tracking triggers and flare timing matters for treatment decisions.
- Target buyer: Adult eczema or psoriasis patient tracking flares between dermatology visits

### Problem severity - 6.5/10 (22% weight)
Problem severity is promising when the buyer pain, customer value, and dream-outcome scores are combined.

- Patients struggle to recall when flares started, what triggered them, and whether treatment is working, so dermatology visits rely on vague memory instead of dated photo evidence.
- Eczema and psoriasis are relapsing-remitting conditions where tracking triggers and flare timing matters for treatment decisions.

### Willingness to pay - 6.8/10 (20% weight)
Willingness to pay is thin; the model has a monetization hypothesis, but it must still be proven through paid pilots or explicit pricing objections.

- Subscription for unlimited history, exports, and a visit-prep summary PDF.
- Recruit fifteen eczema patients to log photos weekly for one month, then ask their dermatologist whether the timeline changed the visit and measure willingness to pay.

### Competitive saturation - 5.5/10 (18% weight)
Competitive room is reduced by 2 recorded alternative(s); the wedge must stay narrow and differentiated.

- Recorded alternative: Imagine by Eczema
- Competitive score rewards a narrow wedge, not absence of research.

### Feasibility - 7.8/10 (16% weight)
Feasibility is strong for a low build if the MVP is limited to the first measurable workflow.

- Recruit fifteen eczema patients to log photos weekly for one month, then ask their dermatologist whether the timeline changed the visit and measure willingness to pay.
- Must avoid implying any diagnosis or treatment decision and clearly support, not replace, clinical care.

## Market gap
Underserved segments:
- Adult eczema or psoriasis patient tracking flares between dermatology visits who still run the workflow in spreadsheets, generic docs, email, or chat threads.
- Small teams in Chronic skin condition self-management that feel the pain weekly but are too narrow for broad incumbents.
- New adopters who need guided proof before committing to a larger platform.

Feature gaps:
- A narrow workflow that reaches value without configuration-heavy onboarding.
- A buyer-facing proof artifact that shows time saved, risk reduced, or communication improved.
- A handoff path from manual concierge service to repeatable software.

Differentiation levers:
- Use specificity as the wedge: one buyer, one workflow, one measurable result.
- Show proof earlier than broad competitors with before-and-after examples and small pilot data.
- Keep implementation lighter than incumbent suites or generic AI assistants.

## Roast and risks
Promising enough to test, not strong enough to build broadly.

Blind spots:
- Must avoid implying any diagnosis or treatment decision and clearly support, not replace, clinical care.
- A broad AI assistant can flatten differentiation unless the wedge is painfully specific.
- The first release can become a generic dashboard if the job is not named tightly.

Hard questions:
- Who wakes up already trying to solve this?
- What do they stop paying for or stop doing when this works?
- What proof would make a skeptical buyer trust it in one screen?
- What is the smallest paid version of this idea?

## Kill criteria
- Fewer than five qualified buyers agree to discuss the workflow after targeted outreach.
- No buyer can name a current cost in time, money, risk, or reputation.
- The first demo does not produce a clear next step, paid pilot, or specific objection.

## Offer ladder
- **Lead magnet (Free)**: Flare-timeline Photo Journal For Eczema And Psoriasis Patients checklist Goal: Capture qualified leads and learn the buyer's exact language. Value: Helps Adult eczema or psoriasis patient tracking flares between dermatology visits audit the painful workflow before buying software.
- **Frontend offer ($19-$99)**: Concierge review or paid template Goal: Validate urgency, workflow fit, and willingness to pay. Value: Delivers the first useful output manually before automation is trusted.
- **Core offer ($49-$499/month)**: Flare-timeline photo journal for eczema and psoriasis patients focused SaaS Goal: Create the recurring revenue product after the narrow wedge survives tests. Value: Turns the recurring manual workflow into a repeatable product loop.
- **Continuity ($99-$1,000/year add-on)**: Monitoring, benchmarks, and monthly reporting Goal: Increase retention and make the product part of a routine. Value: Keeps the buyer engaged with ongoing proof, saved time, or reduced risk.
- **Backend offer (Custom)**: Done-with-you setup, agency, or team rollout Goal: Capture higher-value accounts once the productized wedge is proven. Value: Adds implementation help, integrations, and workflow migration.

Print-ready memo

Decision Memo: Flare-timeline photo journal for eczema and psoriasis patients

Team verdict: Park
Validation verdict: Research / 64/100
Confidence: 62%
Recorded: Not recorded

Recommendation

Keep this parked until the team has evidence for the next validation step: Recruit fifteen eczema patients to log photos weekly for one month, then ask their dermatologist whether the timeline changed the visit and measure willingness to pay.

Team rationale

No team rationale recorded yet.

Reviewers

No named reviewers recorded.

Source anchors

Buyer: Adult eczema or psoriasis patient tracking flares between dermatology visits
Market: Chronic skin condition self-management
Problem: Patients struggle to recall when flares started, what triggered them, and whether treatment is working, so dermatology visits rely on vague memory instead of dated photo evidence.
Thesis: Flare-timeline photo journal for eczema and psoriasis patients should be tested as a narrow first-win workflow for Adult eczema or psoriasis patient tracking flares between dermatology visits.

Validation rubric

Demand signal

24% weight

5.6/10

Demand looks thin because the report has 2 source-backed signal(s), an editorial confidence of 62/100, and a defined buyer in Chronic skin condition self-management.

Problem severity

22% weight

6.5/10

Problem severity is promising when the buyer pain, customer value, and dream-outcome scores are combined.

Willingness to pay

20% weight

6.8/10

Willingness to pay is thin; the model has a monetization hypothesis, but it must still be proven through paid pilots or explicit pricing objections.

Competitive saturation

18% weight

5.5/10

Competitive room is reduced by 2 recorded alternative(s); the wedge must stay narrow and differentiated.

Feasibility

16% weight

7.8/10

Feasibility is strong for a low build if the MVP is limited to the first measurable workflow.

Market gap

Underserved segments

Adult eczema or psoriasis patient tracking flares between dermatology visits who still run the workflow in spreadsheets, generic docs, email, or chat threads.
Small teams in Chronic skin condition self-management that feel the pain weekly but are too narrow for broad incumbents.
New adopters who need guided proof before committing to a larger platform.

Feature gaps

A narrow workflow that reaches value without configuration-heavy onboarding.
A buyer-facing proof artifact that shows time saved, risk reduced, or communication improved.
A handoff path from manual concierge service to repeatable software.

Differentiation levers

Use specificity as the wedge: one buyer, one workflow, one measurable result.
Show proof earlier than broad competitors with before-and-after examples and small pilot data.
Keep implementation lighter than incumbent suites or generic AI assistants.

Roast and risks

Promising enough to test, not strong enough to build broadly.

Blind spots

Must avoid implying any diagnosis or treatment decision and clearly support, not replace, clinical care.
A broad AI assistant can flatten differentiation unless the wedge is painfully specific.
The first release can become a generic dashboard if the job is not named tightly.

Hard questions

Who wakes up already trying to solve this?
What do they stop paying for or stop doing when this works?
What proof would make a skeptical buyer trust it in one screen?
What is the smallest paid version of this idea?

Kill criteria

Fewer than five qualified buyers agree to discuss the workflow after targeted outreach.
No buyer can name a current cost in time, money, risk, or reputation.
The first demo does not produce a clear next step, paid pilot, or specific objection.

Offer ladder

Lead magnet